Dr. Baskies is a specialist in surgical oncology and general surgery, affiliated with Virtua Health Systems. He is former Chairman of the National Board of Directors of the American Cancer Society and current Chair of the society’s Global Cancer Control Advisory Council. He is a member of the Global Breast ...
Dr. Budd is a specialist in breast cancer and the principal investigator of the Cleveland Clinic and Anixa partnered Phase 1 trial of the Breast Cancer Vaccine. He is Professor of Medicine in the Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic Cancer Center, and Professor in the ...
Dr. Butterfield is a tenured academician (UCLA and University of Pittsburgh) and former President of the Society of Immunotherapy of Cancer (SITC). She is an Adjunct Professor of Microbiology and Immunology at UCSF, a member of the UCSF Helen Diller Family Comprehensive Cancer Center, Cancer Immunotherapy, and core faculty at ...
Dr. Czerniecki is the Chair and Senior Member in the Moffitt Cancer Center Department of Breast Oncology and a renowned surgeon and physician scientist investigating the development of vaccines for the prevention of breast cancer and other solid tumors. He is recognized nationally for his contribution to the development of ...
Dr. Leyland-Jones is a pre-eminent clinical trialist in oncology and the recipient of numerous awards. He is the Chief Medical Officer of AIM-HI Accelerator Fund, OTraces, and the N OF 1 Mission. In addition, he is a Scientific Advisory Board Member of the National Foundation for Cancer Research and NED ...
Dr. Rugo is a leader and specialist in breast cancer research and recipient of numerous awards. She is Professor, Department of Medicine (Hematology/Oncology), and Director, Breast Oncology and Clinical Trials Education, at the UCSF Helen Diller Family Comprehensive Cancer Center. She is Co-chair of the Triple Negative Working Group, a member ...
Latest News & Events
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting
Read More...Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank
Read More...Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
Read More...